Abstract:The physicochemical properties of lanthanides, and of their derivatives, contribute essential functions to a range of modern‐day materials and processes. Some fundamental thermodynamic and electrochemical features of lanthanide halide melts are presented. They are illustrated by a few selected examples of relevance for applications ranging from pyroreprocessing of spent nuclear fuel to electrochemical molten salt synthesis of materials.
“…TbCl 3 exhibits a phase transition at 790 K with crystal structure changing from orthorhombic PuBr 3 -type to orthorhombic trirutile-type. DyCl 3 transforms from low temperature monoclinic (AlCl 3 -type) to orthorhombic (PuBr 3 type) at 611 K. The subsequent lanthanides (Ho to Lu) have monoclinic AlCl 3 -type structure [12]. The different general trends in the variation of stability of Ln 2 O 3 and LnCl 3 compounds provide a tool for the separation of lanthanides.…”
“…TbCl 3 exhibits a phase transition at 790 K with crystal structure changing from orthorhombic PuBr 3 -type to orthorhombic trirutile-type. DyCl 3 transforms from low temperature monoclinic (AlCl 3 -type) to orthorhombic (PuBr 3 type) at 611 K. The subsequent lanthanides (Ho to Lu) have monoclinic AlCl 3 -type structure [12]. The different general trends in the variation of stability of Ln 2 O 3 and LnCl 3 compounds provide a tool for the separation of lanthanides.…”
Molten salt matrices were used to evaluate outer-coordination sphere effects on lanthanide redox chemistry. Results were rationalized by correlating the polarization power of the outer-sphere cation with shifts in the Ln3+/Ln2+ reduction potentials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.